chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning a male between 12-15 months who in approximately February 2006, "in the past month", was vaccinated SC with a 0.5 ml dose of varicella virus vaccine live (Lot # 650233/0912R). On approximately 01-FEB-2006, "two weeks ago", the patient experienced breakthrough lesions. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.28
Sex: F
Vaccine: VARCEL
Symptoms: Eczema, Skin ulcer
Clinical narrative: Information has been receive from a registered nurse concerning a 26 month old white female with no known allergies or history who on 16-FEB-2005 was vaccinated in the left arm with a first dose of varicella virus vaccine live (lot# 648757/0594P). There was no illness at the time of vaccination. On 02-FEB-2006 the patient developed 5 lesions on trunk with patches of eczema. Unspecified medical attention was sought. The patient was treated with diphenhydramine hydrochloride (BENADRYL) and topical skin care. No laboratory diagnostic tests were performed. Subsequently, the patient recovered.  No further information is available.
Age: 1.3
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Herpes zoster, Infection
Clinical narrative: Information has been received from a physician concerning a 15 month old male who, at 12 months of age, was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccinations administered on that same day included a dose of MMR. The physician reported that the patient subsequently developed a severe case of shingles after being vaccinated with varicella virus vaccine live. Unspecified medical attention was sought and the patient was subsequently hospitalized. It was noted that lesions were collected from the patient and cultures (group A strep) were being grown to see if isolates were from the vaccine. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.53
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an 18 month old male with no pertinent medical history and no drug reactions/allergies who on 03-FEB-2006 was vaccinated SC with a 0.5mL dose of varicella virus vaccine live (Lot # 652555/1023R). There was no concomitant medication. On 14-FEB-2006 the patient was diagnosed with chickenpox. However, on 15-FEB-2006, he presented to the office and the physician deemed that the patient did not have chickenpox. The patient was diagnosed with viral exanthem. The outcome was reported as not recovered. There were no lab diagnostic studies performed. There was no product quality complaint. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning an 8 year old male with no known medical history who at 12 months of age, in approximately 1999, was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. in February 2006, the patient experienced a case of breakthrough. He developed less than 50 vesicles on his thorax and torso. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 41 year old female with hypertension, gastroesophageal reflux disease and a penicillin allergy and a history of hepatitis B, who on 08-DEC-2005 had a varicella titer done it showed no immunity, therefore, on 26-JAN-2006 was vaccinated in the arm with a dose of varicella virus vaccine live. Concomitant therapy included omeprazole. On 08-FEB-2006 the patient developed a rash, first on her vaccinated arm (unspecified), then on her back and chest. She called he physician on 11-FEB-2006 and was seen. The patient was unable to work from the onset of the rash on 08-FEB-2006 until 14-FEB-2006. At the time of this report the patient was recovering. It was also noted that on 14-FEB-2006 she was started on acyclovir (ZOVIRAX) 500 mg, PO for 5 days. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin ulcer, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 3 year old female with no known medical history who was vaccinated at 12 months of age with a dose of varicella virus vaccine live. There was no concomitant medication. In February 2006, the patient developed breakthrough with less than 50 lesions on her torso and scattered on body. Unspecified medical attention was sought. The patient recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician concerning a 4 year old white male with no known drug allergies (NKDA) who on 22 January 2002, was vaccinated in the left arm with the first dose of varicella virus vaccine live (Oka/Merck) ( Lot #63127/1237L). Concomitant vaccinations administered on that same day included the fourth dose in the left thigh of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (P484-139). There was no other concomitant medications. The physician reported that in January 2006, the patient developed a mild chickenpox rash. No laboratory or diagnostic tests were performed as medical attention was not sought. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Age: 1.07
Sex: F
Vaccine: FLUX, HIBV, MMR, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 14 month old female with a normal immune status who on 10 January 2006, was vaccinated subcutaneously in the left arm with a 0.5ml dose of varicella virus vaccine live (Oka/Merck) (lot #645164/0064R). Concomitant therapy that day included Hib conj vaccine (OMPC) (manufacturer unknown), measles mumps rubella vaccine (MSD) and influenza virus vaccine (unspecified). The patient's mother called to report that on 16 February 2006, her daughter developed a "line" of tiny vesicular lesions on her left side. She described the line as 2-3 inches wide and about 6 inches long. From the description the nurse felt this may be shingles. It was noted that the patient had not been in for an exam. No labs were done. At the time of this report the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Medication error
Clinical narrative: Information has been received from a health professional concerning a 12 month old male with no medical history and no allergies who on 16 February 2006, was vaccinated intradermally in the left forearm with a dose of varicella virus vaccine live (Oka/Merck) (lot#649741/0222R). There was no concomitant medication. On 16 February 2006, the same day, the patient experienced redness at the injection site. Unspecified medial attention was sought, but no labs were done. At the time of reporting the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Infection
Clinical narrative: Information has been received from a physician concerning a 14 to 16 year old obese male who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The physician reported that when the patient was 4 to 6 years old he developed a mild case of shingles. Unspecified medical attention was sought and the patient was treated with acyclovir ointment. Two weeks after the initial diagnosis, the patient's shingles resolved. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Rash pustular, Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 42 month old male who on 10 March 2005 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The RN reported that on 15 February 2006, the patient developed chickenpox. Unspecified medical attention was sought. At the time of this report, the patient's chickenpox persisted. Additional information has been requested. This is in follow-up to report(s) previously submitted on 05/12/2006. Information has been received from a physician and a registered nurse concerning a 42-month-old male with no medical history who on 10-MAR-2005 was vaccinated SC in the left arm with the first dose of VARIVAX (Merck) (lot #649846/0767P). The RN reported that on 05-FEB-2005 (also reported as 15-FEB-2006), the patient developed chickenpox characterized by vesicles and pustular papules on his trunk. Unspecified medical attentionwas sought. In 2006, the patient's chickenpos subsequently resolved. Additional information is not expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician concerning an 8 year old male who on 22 June 1998, was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. In November 2005, the patient experienced mild breakthrough chickenpox. The case was so mild that the patient's mother did not report it to the physician's office and the children had no medical attention. Outcome was not reported. No product quality complaint was involved. The patient's sister (WAES #0602USA04816) had a similar experience after vaccination with varicella virus vaccine live (Oka/Merck). Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Nasopharyngitis
Clinical narrative: Information has been received from a physician concerning a 2 year old female who on 23 April 2004, was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (Lot #647087/0851N). The physician reported that on 02 February 2006, the patient presented to the physician's office with breakthrough chickenpox characterized by lesions at various stages. The physician also reported that the patient also had nasopharyngitis at the time of her breakthrough chickenpox. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician concerning a 4 year old female who on 17 November 2003, was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) ( lot # 642683/0326M). There was no concomitant medication. In November 2005, the patient developed a mild break through case of chickenpox. The case was so mild, the mother did not bring it to her physician's attention at the time. A product complaint was not involved. Additional information has been requested. The patient's brother had a similar experience after therapy with varicella virus vaccine live (Oka/Merck) (WASE # 0602USA04774).
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Information has been received from a health professional concerning an 8 year old female with no known medical history or allergies who "several years ago" was vaccinated with a 0.5 ml subcutaneous dose of varicella virus vaccine live (Oka/Merck) (lot # 627868/1258H). There was no concomitant medication. On 11 February 2006, the patient developed 20 vesicular lesions that crusted over during the next few days. Unspecified medical attention was sought. No other symptoms were noted. The patient was treated with diphenhydramine hydrochloride and calamine lotion. NO laboratory diagnostic test were performed. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a pharmacist concerning a patient who on 31 January 2006, was vaccinated with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). On 18 February 2006, the patient developed a chickenpox rash. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a health professional concerning a 9 year old male with migraines and speech impairment and no known drug reactions or allergies who on 04 January 2000, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Concomitant therapy included cyproheptadine hydrochloride. On 13 February 2006, the patient presented with 50-100 varicella lesions and was diagnosed with varicella. There was no fever or other symptoms. The lesions were papular with no scabbing. The patient recovered in 7 days. No laboratory diagnostic tests were performed. There was no product quality complaint involved. It was reported that the patient's brother (WAES# 0603USA00313) had a similar experience after vaccination with varicella virus vaccine live (Oka/Merck). No further information is available.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster, Infection
Clinical narrative: Information has been received from a physician concerning a 12 month old patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The child appeared to have shingles. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a nurse practitioner concerning a 6 yr old male who on 27Jul00 was vaccinated with a dose of varicella virus vaccine live. On 19Feb06, the pt developed a moderate case break through chickenpox characterized by approx 100 vesicular lesions. He was noted to be afebrile. Unspecified medical attention was sought and he was treated with diphenhydramine hydrochloride (Benadryl). A product quality complaint was not involved. Breakthrough chickenpox was determined to be an other important medical event (OMIC) by the reporter. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Clinical narrative: Information has been received from a physician concerning a 6 year old male who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced mild breakthrough chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. The patient's sister (WAES 0603USA00508) had a similar experience after vaccination with varicella virus vaccine live (Oka/Merck). Additional information has been requested. Follow up information from the physician indicated that he did not remember the patient's name. He only knew that he had a kid who broke out wiht a few red bumps and might have had a mild case of breakthrough varicella. There were no cultures or blood tests done. The patient's sister (WAES 0603USA00508) had a similar experience after vaccination with VARIVAX (Merck). Additional information is not expected.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a medical assistant concerning a 12 year old male patient who on 25 October 1999 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On approximately 28 December 2005, the patient developed chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a physician's assistant concerning a male patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and "now", on 22 February 2006, has breakthrough chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash papular
Clinical narrative: Information has been received from a health professional concerning a 12 month old female, with on medical history or allergies, who on 10 February 2006 was vaccinated with a 0.5 ml subcutaneous dose of varicella virus vaccine live (Oka/Merck) (Lot# 652447/0946R). There was no concomitant medication. On 20 February 2006, the patient experienced a rash with less than 20 erythematous papules on her torso and extremities. The patient was treated with diphenhydramine hydrochloride (Benadryl), acetaminophen (Tylenol), and oatmeal baths as needed. At the time of the report the patient had not recovered. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No further information was provided. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a health professional concerning a 13 year old female with no known drug allergies who on 02 August 2004, was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). On 05 February 2006, the patient developed a mild case of chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a health professional concerning a 6 year old male who on 08 February 2006, was vaccinated subcutaneously with 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot # "0829R"). On 21 February 2006, the patient presented to the school nurse with chickenpox with 40-50 lesions on his trunk, hair line and face with a temperature of 99 degrees F. Prior to visiting the school nurse the patient was being treated with benzocaine (+) resorcinol (Lanacane). Unspecified medical treatment was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Rash
Clinical narrative: Information has been received from a nurse concerning a 6 yr old male who on 31Mar00 was vaccinated with a dose of varicella virus vaccine live (lot631076/0453J). On 22Feb06 the pt experienced shingles characterized by a T2 dermatomal rash. Unspecified medical attention was sought and the pt was treated with acyclovir. No outcome information was reported. No product quality complaint was involved. The reporter considered the pt's adverse experience to be an other important medical event (OMIC). Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a physician concerning a 5 year old male with no allergies or medical history who was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On 22 February 2006, the patient was seen in the office for break through chickenpox. He had approximately 20 lesions. Since then itchy lesions were not relieved with diphenhydramine hydrochloride (Benadryl) at home, the physician prescribed hydroxyzine hydrochloride (Atarax). No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin ulcer
Clinical narrative: Info has been received from a physician concerning a 7 year old male who, at 12 months of age, was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 2/23/06, the pt presented with about 25 lesions on his torso that they thought might be chickenpox but the physician was unsure of the diagnosis. Unspecified medical attention was sought. No diagnostic lab tests were performed. At the time of the report, the pt had not recovered. A product quality complaint was not involved. Additional info has been requested.
Age: 1.03
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a health professional concerning a 7 year old female with unknown drug allergies, who on 11-AUG-1999 was vaccinated with a 0.5ml subcutaneous dose in the "right" of varicella virus vaccine live (Oka/Merck) (Lot #6699J). The second week of February 2006 on approximately 08-FEB-2006, the patient got a mild case of chickenpox from her sister. Unspecified medical attention was sought. No product quality complaint was involved. The patient's sister also experienced chickenpox following vaccination with varicella virus vaccine live (Oka/Merck) (WAES#0603USA00490). Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Rash Vesicular Information has been received from a physician concerning a 7 year old female who on 23-MAY-2000 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 20-FEB-2006 the patient broke out with vesicular lesions. It was reported that the patient was told to use diphenhydramine hydrochloride (Benadryl), calamine lotion, and hot compresses. At the time of the report the patient was recovering. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.57
Sex: M
Vaccine: VARCEL
Symptoms: Abdominal pain upper, Infection, Vomiting
Clinical narrative: Information has been received from a health professional concerning a male patient who on 13 March 2000, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced stomach pain, vomiting and a generalized chickenpox rash. The patient was being treated with acyclovir. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The patient's reaction was considered to be an other important medical event by the reporter. Additional information has been requested. (OMIC)
Sex: M
Vaccine: DTOX, FLUX, MMR, TTOX, VARCEL
Symptoms: Herpes zoster
Clinical narrative: Herpes Zoster Information has been received from a registered nurse (RN) concerning a male in his 60s year who on 20-JAN-2006 was vaccinated with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccinations administered on that same day included a dose of measles virus vaccine live (Enders-Edmonston)(+) mumps virus vaccine live (Jeryl Lynn((+) rubella virus vaccine live (Wistar RA 27/3)(MSD), a dose of influenza virus vaccine (unspecified) and diphtheria toxoid (+) tetanus toxoid. The RN reported that in 2006 the patient developed a rash. The patient went to a free clinic where a diagnosis of shingles was made. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.11
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a certified medical assistant (CMA) concerning a 4 year old white female who on 10-JAN-2003 was vaccinated SC in the right arm with a dose of varicella virus vaccine live (Oka/Merck) (Lot #641155/0793M). The CMA reported that on 12-JAN-2006 the patient developed chickenpox. Symptomatic care was discussed with the patient's mother. On 20-JAN-2006 the patient's chickenpox resolved. No further information is available.
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a woman in a physician's office concerning a male who on 23-NOV-1998 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The woman reported that on 18-FEB-2006 the patient developed chickenpox symptoms after being exposed to chickenpox two weeks prior. The patient was noted to be afebrile. Medical attention was not sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.04
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Varicella Information has been received from a physician concerning a 6 year old male who was vaccinated with varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced very few chickenpox spots. He was not itching, no fever or complications were noted. It was reported that the patient had been exposed at school Additional information has been requested. 05/16/2007 Information has been received from a physician and a nurse concerning a 6 year old female (initially reported as male) who on 29-NOV-2001 was vaccinated with VARIVAX. On 15-MAR-2006 the patient had an onset of chicken pox breath thru with very few chicken pox spots (less than 50 lesions). She was not itching, and no fever or complications were noted. It was reported that the patient had been exposed at school. Subsequently the patient recovered. No treatment was necessary, just comfort measures as needed. The nurse also reported on two other patients who experienced adverse events after being vaccinated with VARIVAX (WAES # 0703USA05015 and #0703USA05016). Additional information is not expected.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a consumer concerning a 9 year old male with down's syndrome and a penicillin allergy who in approximately 1999 "at a little over two" was vaccinated SC with a dose of varicella virus vaccine live (Oka/Merck). Concomitant therapy included levothyroxine NA (Synthroid), omeprazole (Prilosec) methylphemidate HCL (Metadate) and "risperdal". On 23-FEB-2006 the patient experienced breakthrough chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a consumer concerning a 6 year old female with no medical history or allergies who at 12 months of age was vaccinated SC with a dose of varicella virus vaccine live. There was no concomitant therapy. It was reported on 23-FEB-2006 the patient developed breakthrough chickenpox most of which was on her face. Unspecified medical attention was sought but no laboratory/diagnostic tests were performed. At the time of this report the patient was recovering from the chickenpox. It was also reported that the patient's brother (WAES0602USA05787) and sister (WAES0602USA05795) developed chickenpox after vaccination with varicella virus vaccine live. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a consumer concerning a 6 year old female with an allergy to sulfa based drugs and no known medical history who "at 12 months of age" was vaccinated SC with a dose of varicella virus vaccine live.  There was no concomitant medication.  On 22-FEB-2006 the patient developed breakthrough chickenpox.  The pox were located on her trunk, and several on her face.  Unspecified medical attention was sought.  No laboratory diagnostic tests were performed.  There was no product quality complaint involved.  Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 10-year-old female with insulin-dependent diabetes mellitus (IDDM) and no allergies, who on 13-MAR-2000 was vaccinated subcutaneously in the left arm with a dose of varicella virus vaccine live.  Concomitant therapy included insulin.  On 27-FEB-2006, after being exposed to chickenpox, the patient had a varicella titer drawn.  The titer showed that the patient was not immune to chickenpox.  Unspecified medical attention was sought.  It was reported that at the time of this report the child was well with controlled IDDM.  No product quality complaint was involved.  Additional information has been requested.
Age: 6.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a school age patient who was vaccinated with a dose of varicella virus vaccine live.  "last week", in February 2006, the patient experienced chickenpox.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/12/2006. Information has been received from a physician concerning a 6 year old patient who in 1997 or 2000, was vaccinated with a dose of VARIVAX (MERCK). "Last week", in February 2006, the patient experienced chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the patient had a small amount of vesicles. It was reported that the vesicles had cleared completely. No other information was provided. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from an employee at a physician's office concerning a 5-year-old white female who on 09-MAY-2001 was vaccinated SC with a second dose of varicella virus vaccine live.  On 06-FEB-2006, the patient developed a papulovesicular rash on the upper torso, "20 to 30", and had no fever.  The patient recovered on 13-FEB-2006.  No further information is expected.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a physician concerning a kid who was vaccinated with a dose of varicella virus vaccine live.  On approximately 25-FEB-2006 the patient experienced varicella breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint involved.  Additional information has been requested.
Age: 1.38
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a woman in a physician's office concerning a 9 year old white male, with no medical history and no allergies, who on 3/20/98 was vaccinated with a 1st dose of varicella virus vaccine live. Concomitant vaccine included a 1st dose of MMRII. There was no illness at the time of vaccination. On 2/19/06, the pt broke out with varicella, described as a mild case. It was reported that a full recovery was expected. Medical attention was not sought. Additional info has been requested.
Age: 1.01
Sex: F
Vaccine: FLUX, MMR, PNC, VARCEL
Symptoms: Rash papular
Clinical narrative: Information has been received from a health professional concerning a 14 month old female with a history of bronchiolitis and no known allergies, who on 12 December 2005 (also reported on 05 December 2005), was vaccinated subcutaneously in the right arm with a 0.5 Ml dose of varicella virus vaccine live (lot # 650231/1114P). Concomitant vaccination that day included a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CMR197) (Prevnar), a dose of influenza virus vaccine (unspecified) and a dose of measles-mumps-rubella vaccine. Concomitant therapy included diphenhydramine hydrochloride (Benadryl). A rash did not occur at the site of injection post vaccination. On 21 February 2006, she had developed a vesiculo-papular rash, also described as a diffuse papular rash, on her face, trunk and extremities. On 22 February 2006, the patient was seen by the physician. The patient was had greater than 100 lesions on her face, trunk and upper arms. Some burrows were noted. The patient was afebrile. The physician assumed it was scabies and the patient was treated with permethrin (Elimite). The patient did not get better and she was seen again on 27 February 2006. She still had a diffuse papular rash, many of which were crusted. The patient's diagnosis was possible varicella. VZVID isolates were requested by the physician. On 28 February 2006, the specimen was obtained from a papule. The specimen was inadequate, negative for b-globuin, no strain was identified. It was noted that there had been no recent exposure to chickenpox or shingles. At the time of the report the patient had not yet recovered. There was no product quality complaint involved. Diffuse papular rash was considered to be an other important medical event. Additional information has been requested. (OMIC)
Age: 1.26
Sex: F
Vaccine: VARCEL
Symptoms: Infection, Pruritus, Rhinorrhoea, Varicella, Varicella post vaccine
Clinical narrative: Info has been received from an RN concerning a 9 year old female with no known medical history who on 8/12/97 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 2/23/06, the pt experienced moderate case of breakthrough. The pt had about 40 itchy lesions and a runny nose. Unspecified medical attention was sought and the treatment was Benadryl and Aveeno baths. At the time of the report, the pt was recovering. Additional info has been requested. Follow-up information indicated that on 23-FEB-2006 the patient developed, mild chickenpox disease. No additional information was provided. No further information was available.
Age: 1.01
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Injection site hypersensitivity, Skin exfoliation, Skin ulcer
Clinical narrative: Info has been received from a physician concerning a 12 month old male with no allergies or medical history who on 2/8/06 was vaccinated SC in the right leg with an 0.5ml dose of varicella virus vaccine live (lot 646816/0631R). Concomitant therapy included pneumococcal 7 valent conjugate vaccine. On 2/22/06, the pt experienced 2 lesions and excoriation at the injection site. The child was afebrile and with no other symptoms. He was seen in the physician's office on 2/28/06 and no labs were done. At the time of this report, the pt was not recovered. No product quality complaint was involved. Additional info has been requested.
Age: 1.9
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a woman in a pediatric office concerning a 10 year old white male student (64 lbs) with no medical history, who on 1/9/98, was vaccinated with a 1st dose of varicella virus vaccine live (lot 624068/1101E). There was no illness at the time of vaccination. On 2/22/06, the pt developed a mild case of varicella. The pt was seen in the physician's office on 2/23/06. No treatment was reported. Subsequently, the pt recovered from varicella. No further info was available at the time of this report. Additional info is not expected.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Info has been received from a health professional concerning a 5 year old male who on 3/15/05 was vaccinated with an 0.5 ml, SC, dose of varicella virus vaccine live (lot 649481/0764P). On 2/27/06, the pt broke out in a rash on his back, legs and stomach, which appeared to be chickenpox lesions at different stages of healing. It was reported that the pt was seen by a physician on 3/1/06 and was dx'd with chickenpox. At the time of the report, the pt was recovering. No product quality complaint was involved. No other info was provided. Additional info has been requested. This is in follow-up to report(s) previously submitted on 5/12/2006. Information has been rceived from a health professional concerning a 5 year old male, with no known allergies, who on 15-MAR-2005 was vaccinated with a first 0.5 ml subcutaneous dose of VARIVAX (Merck) (Lot # 649481/0764P). There was no illness at the time of vaccination. On 27-FEB-2006 the patient broke out in a rash on his back, legs, arms, and stomach, which appeared to be chickenpox lesions at different stages of healing. It was reported that the patient was seen by a physician on 01-MAR-2006 and was diagnosed with chickenpox. At the time of teh report the patient was recovering. No information from a health professional indicated that the patient recovered. Additional information is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a physician concerning an adult female with a history of chickenpox as a child who subsequently, developed a rash over her anterior and posterior trunk and itching after daily exposure to pts who received a dose of varicella virus vaccine live. No treatment was given and no other symptoms occurred. Unspecified medical attention was sought. At the time of this report, the pt was recovering and her rash was noted to be fading. It was also noted, the pt was not a recipient of the vaccine and did not directly administer the vaccine. Additional info has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Scab, Varicella
Clinical narrative: Info has been received from an RN concerning an 8 year old male with allergies; reflux and an allergy to Septra which caused a rash who on 4/19/01 was vaccinated, SC, with an 0.5 mL dose of varicella virus vaccine live (lot 636571/0928K). Concomitant therapy included Zyrtec. The RN reported that on 2/23/06, the pt developed a rash on his trunk. On 2/28/06, the pt was seen by a physician who confirmed the rash and noted it had formed scabs. A diagnosis of chickenpox was made. At the time of this report, the pt's chickenpox persisted. Additional info has been requested.  This is in follow-up to report (s) previously submitted on 5/12/2006.  Information has been received from a licensed practical nurse (LPN) concerning an 8-year-old white male with allergies, reflux and an allergy to SEPTRA which caused a rash who on 09-APR-2001 (also reported as 19-APR-2001) was vaccinated SC with the first 0.5 mL dose of VARIVAX (Merck) (Lot #636571/0928K).  Concomitant therapy included ZYRTEC.  Illness at the time of vaccination included night terrors.  The RN reported that on 23-FEB-2006, the patient developed a rash on his trunk.  On 28-FEB-2006, the patient was seen in the office by a physician who confirmed the rash that was "consistent with varicella".  The total number of lesions were about 50.  At that time, it was noted that the rash had formed scabs.  A diagnosis of chickenpox was made.  On 28-MAR-2006, the patient returned to the office for a follow-up visit.  The chickenpox were considered to be resolved as of 16-MAR-2006.  Additional information is not expected.
Age: 1.52
Sex: M
Vaccine: VARCEL
Symptoms: Nasal congestion, Pyrexia, Rash, Skin ulcer
Clinical narrative: Information has been received from a health professional concerning a 11 yr old male with cashew and walnut allergies and no other medical history who on 24May96 was vaccinated  SC with a 0.5ml dose of varicella virus vaccine live (lot609287/0393B). There was no concomitant medication. On 28Feb06 the pt presented with 28-35 insect bite like lesions on his chest and back. The child also had a low fever and congestion. He was treated with acetaminophen (Tylenol) and household spray starch and applied to the rash. No labs were done. At the time of this report the pt was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Skin ulcer
Clinical narrative: Information has been received from a RN concerning a 12 yr old male with no allergies or medical history who on 04Jun98 was vaccinated with a dose of varicella virus vaccine live. On 27Feb06, the pt developed a rash on his back, chest and legs for three days. He was seen in the physician's office on 01Mar05. The physician noted that he had 50 to 100 lesions and was diagnosed with varicella. A product quality complaint was not involved. Additional information has been requested. It was reported that the pt's brother has a similar reaction after therapy with varicella virus vaccine live (WAES0602USA04848). It was also noted that the patient's brother was diagnosed with chickenpox about 10 years prior to the patient's outbreak.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Exposure to communicable disease, Pyrexia, Rash pruritic
Clinical narrative: Information has been received from a licensed practical nurse concerning a 6 yr old female with no allergies or medical history who on 03Dec01 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 28Feb06, the pt experienced seven to eight little spots, one was blistered, itching, and an oral temp of 100. Unspecified medical attention was sought and she was treated with acetaminophen (Tylenol) and diphenhydramine hydrochloride (Benadryl). No diagnostic lab tests were performed. At the time of the report, the pt had not recovered. A product quality complaint was not involved. Additional information has been requested. Follow-up information was received from the nurse who reported that the patient woke up the morning of 28-FEB-2006 with a low grade fever of 100 degrees and a low (7-8) pox on the arms and abdomen that were itchy. She was exposed to chicken pox at school the previous week. The patient recovered on an unspecified date.
Age: 1.03
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blister, Erythema, Skin discolouration, Skin ulcer
Clinical narrative: Information has been received from a RN concerning a 10 yr old white male with no known preexisting allergies, birth defects or medical conditions who on 25Apr96 was vaccinated in the arm with a first dose of varicella virus vaccine live (lot616997/1656B). There was no known illness at the time of vaccination. Concomitant therapy that day included a first dose of measles mumps rubella vaccine (lot 617129/1469B). On 24Feb06 the pt was noted to have 2 lesions, and following day was noted to have 30 lesions. No fever was noted. The lesions were red, and were noted to get a little blistery, but did not open. It was noted that some lesions just get a little darker in color. The lesions were mostly on the pt's back, chest, and arms and one lesion was noted on the pt's hip. No problems with itching were noted. No new lesions developed after 25Feb06. The pt recovered on 28Feb06. There were no relevant diagnostic tests or lab data. No additional information is expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Viral infection
Clinical narrative: Information has been received from a health professional concerning a female, who on 06Aug96 was vaccinated with a dose of varicella virus live (lot 617001/0246D). Subsequently the pt experienced chickenpox. The pt's sister also experienced chickenpox following vaccination with varicella virus vaccine live (WAES0602USA05492). Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Varicella, Viral infection
Clinical narrative: Information has been received from a physician concerning a 2 yr old female who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt experienced mild breakthrough chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. The pt's brother (WAES0602USA05058) had a similar experience after vaccination with VARIVAX. Additional information has been requested. Follow up information from the physician indicated that the he did not remember the patient's name. He just knew there was a kid who broke out with a few bumps and might have had a mild case of breakthrough varicella. There were no cultures or blood tests done.
Age: 1.01
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Blister, Herpes zoster, Viral infection
Clinical narrative: Information has been received from a  registered nurse concerning a 3-year-old male who on 11-AUG-2004 was vaccinated with a dose of varicella virus vaccine live. Concomitant therapy that day included a dose of Hib conj vaccine (manufacturer unknown) and a dose of measles-mumps-rubella vaccine. On 20-FEB-2006, the patient developed shingles. The patient had blisters on the left thigh and buttocks. The outcome was reported as not recovered. There was no product quality complaint. Additional information has been requested.
Age: 1.21
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular, Varicella
Clinical narrative: Info has been received from a CMA concerning a 6 year old male with no allergies or allergies or medical history who on 7/11/06, was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 2/23/06, the pt experienced a rash with a few vesicles around the throat area. The rash was consistent with chickenpox. Unspecified medical attention was sought and he was treated with Tylenol and Benadryl. No diagnostic lab tests were performed. At the time of the report, the pt was improving. A product quality complaint was not involved. Additional info has been requested.
Age: 0.94
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Pyrexia, Rash vesicular, Varicella
Clinical narrative: Info has been received from an RN concerning a 43 month old male who in May, 1994, was vaccinated, SC, with a 0.5 ml dose of varicella virus vaccine live. It was reported by the pt's mother that on 1/3/97, the pt experienced chickenpox. The child developed more than 50 vesicular lesions and a fever. Subsequently, the pt recovered from chickenpox. According to the pt's mother, on 3/1/06, the pt again developed chickenpox characterized by more than 50 vesicular lesions but no fever. Unspecified medical attention was sought. The child has not been seen by a HCP and no diagnostic studies have been done. At the time of this report, the child was said to be recovering and was taking OTC Benadryl. Additional info has been requested. Additional information has been received from the registered nurse on 04-MAY-2006 indicating hat she called the child's mother and has not received a return call or response from her. The nurse, therefore, has no further information at the time of this report.
Age: 1.05
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Scar, Varicella
Clinical narrative: Information has been received from a physician concerning her 6 yr old daughter with no medical history who, at one year of age, in 2000, was vaccinated with a dose of varicella virus vaccine live. On 28Feb06, the pt developed a rash of over 100 lesions. It was not reported over what body areas the rash appeared. No other symptoms were reported. Unspecified medical attention was sought. At the time of the report, the child was recovering and no treatment was necessary per the physician. A product quality complaint was not involved. Follow up information was received from the physician who reported that on 28Feb06, her daughter developed breakthrough chickenpox. Additional information has been requested. The physician also reported that her 15 month old daughter experienced chickenpox following vaccination with varicella virus vaccine live (WAES0603USA02407). Additional information has been received from the physician indicating that her 6-year-old daughter was vaccinated on 26-JUL-2000 with a dose of VARIVAX. On 28-FEB-2006, the patient developed a varicella rash of approximately 7- lesions. No fever. Some itching. The patient missed school days and had the appearance scarring. It was reported the patient recovered as of 06-MAY-2006.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Acne, Blister, Cough, Drug ineffective, Pruritus
Clinical narrative: Information has been received from a RN concerning a 7 yr old male with no allergies or medical history who on 28Jan00 was vaccinated with a dose of varicella virus vaccine live (lot631769/1016J). There was no concomitant medication. On 01Mar06, the pt developed chickenpox with itchy, crusting, pimple like blisters, and a cough. No diagnostic lab tests were performed. Unspecified medical attention was sought. At the time of the report, the pt had not recovered. A product quality complaint was not involved. Additional information has been requested.